Back

Incidence and predictors of cardiovascular adverse events after anthracycline-containing chemotherapy in lymphoma: a retrospective longitudinal cohort

30 August 2026 (08:15 - 08:45)
Organised by: Logo
Congress Presentation Part of: Early and late cardiovascular complications after haematological therapies Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Dewan Zhao

First Affiliated Hospital of Dalian Medical University, Dalian (China)

4 More presentations in this session

Presentation thumbnail
Long-term prognostic significance of cardiovascular complications following hematopoietic stem cell transplantation: a prospective regional cohort analysis
Associate Professor F. Guerra (Ancona, IT)
Abstract Slides Video
Presentation thumbnail
Product-dependent cardiac functional trajectories following CD19 CAR-T therapy in diffuse large B-cell lymphoma
Doctor I. Sunayama (Nishinomiya, JP)
Abstract Slides Video
Presentation thumbnail
Predictors, incidence, and clinical implications of arrhythmia following CAR-T therapy: a competing-risk analysis
Doctor H. Patel (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Cardiovascular magnetic resonance characterisation of early myocardial changes following allogeneic hematopoietic stem cell transplantation and their clinical predictors
Doctor K. Chan (Melbourne, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Early and late cardiovascular complications after haematological therapies

The Event

Event poster

ESC Congress 2026

30 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Incidence of cancer treatment-related cardiotoxicity in patients with lymphoma treated with non-pegylated liposomal doxorubicin
21 June 2025
thumbnail
Congress Presentation
Cardiovascular risk assessment in multiple myeloma patients undergoing carfilzomib therapy: a new risk prediction model for cardiovascular adverse events
12 December 2020
thumbnail
Congress Presentation
Incidence of acute cardiovascular hospitalizations and association with hemodynamic biomarkers in cancer patients treated with Immune Checkpoint Inhibitor therapy
21 June 2025
thumbnail
Congress Presentation
The role of natriuretic peptide as an early predictor of subclinical anthracycline therapy related cardiotoxicity
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources